Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Leukemia, Myeloid, Acute 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Leukemia, Lymphocytic, Chronic, B-Cell 19Myelodysplastic Syndromes 17Hodgkin Disease 17Lymphoma, Non-Hodgkin 15Myeloproliferative Disorders 13Multiple Myeloma 13Lymphoma, Mantle-Cell 13Leukemia, Myelomonocytic, Chronic 13Lymphoma, Large B-Cell, Diffuse 11Leukemia, Myeloid, Chronic-Phase 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Leukemia, Prolymphocytic 10Waldenstrom Macroglobulinemia 9Lymphoma, Follicular 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Biphenotypic, Acute 7Burkitt Lymphoma 7Anemia, Refractory, with Excess of Blasts 7Primary Myelofibrosis 6Myelodysplastic-Myeloproliferative Diseases 6Lymphoma 5Graft vs Host Disease 5Congenital Abnormalities 5Blast Crisis 5Recurrence 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Prolymphocytic, T-Cell 4

Interventions

Docetaxel 171Radiotherapy 144Magnetic Resonance Spectroscopy 142Leuprolide 112Prednisone 108enzalutamide 102Radiosurgery 101Abiraterone Acetate 94Androgen Antagonists 91Goserelin 83bicalutamide 81gallium 68 PSMA-11 70Surveys and Questionnaires 63apalutamide 57Specimen Handling 56acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 55Radiation 47Gonadotropin-Releasing Hormone 45Standard of Care 44Biopsy 44Brachytherapy 42Radiotherapy, Intensity-Modulated 40Blood Specimen Collection 40darolutamide 39abiraterone 39cabazitaxel 35Exercise 35Carboplatin 33Pluvicto 32Triptorelin Pamoate 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Prostatic Neoplasms × Cyclosporins × Clear all
NCT00824811 2012-08-02

Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel

M.D. Anderson Cancer Center

Phase 2 Withdrawn
BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Lacrimal Apparatus Diseases, Lung Neoplasms, Endophthalmitis, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Lacerations, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡